You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BRCA 1/2

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

PREDICTION OF GERMLINE BRCA 1/2 GENES FROM HEALTHY OVARIES

Not yet recruiting
  • BRCA Mutation
  • +2 more
  • Germinal BRCA
  • (no location specified)
Mar 3, 2023

Breast Cancer, Ovarian Cancer, Pancreas Cancer Trial (TNG348, Olaparib)

Not yet recruiting
  • Breast Cancer
  • +7 more
  • (no location specified)
Sep 26, 2023

Ultra-rapid BRCA1/2 Status Screening Test in Theranostic

Not yet recruiting
  • Breast Cancer
  • Questionnaires
  • Communication of the results of the BRCA1/2 ultra rapid test
  • (no location specified)
Oct 26, 2023

Breast Cancer, Genetic Predisposition Trial in Rome, Varese (Genetic predisposition to breast cancer)

Recruiting
  • Breast Cancer
  • Genetic Predisposition
  • Genetic predisposition to breast cancer
  • Rome, Italy
  • +1 more
May 4, 2023

Breast Cancer, Ovarian Cancer, Breast Tumors Trial in Dnipro, Kyiv (Axitinib)

Enrolling by invitation
  • Breast Cancer
  • +7 more
  • Dnipro, Ukraine
  • +1 more
Jun 17, 2023

Breast Cancer, Metastatic Breast Cancer, BRCA1 Gene Mutation Trial in Boston (ABT-888, temozolomide)

Active, not recruiting
  • Breast Cancer
  • +3 more
  • Boston, Massachusetts
  • +2 more
Dec 21, 2022

BRCA and NACT in TNBC Patients

Completed
  • Triple-Negative Breast Cancer
  • BRCA1/2 genetic testing
  • Rome, RM, Italy
    Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Feb 20, 2023

BRCA1/2 Flu Vaccine

Active, not recruiting
  • BRCA1 Mutation
  • BRCA2 Mutation
  • Seasonal influenza vaccine
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Aug 16, 2022

Quality of Life Post Salpingo-oophorectomy in BRCA1/2 & PALB2

Recruiting
  • Hereditary Breast and Ovarian Cancer
    • Barcelona, Spain
      Hospital de la Santa Creu i Sant Pau
    Jun 3, 2022

    Pancreatic Acinar Cell Carcinoma, Pancreatic Adenocarcinoma, Pancreatic Adenosquamous Carcinoma Trial (Nab paclitaxel,

    Not yet recruiting
    • Pancreatic Acinar Cell Carcinoma
    • +6 more
    • Nab paclitaxel
    • +5 more
    • (no location specified)
    Oct 30, 2023

    Triple Negative Breast Tumors, Triple Negative Breast Cancer, Breast Tumors Trial (Pembrolizumab, Paclitaxel, Carboplatin)

    Not yet recruiting
    • Triple Negative Breast Neoplasms
    • +7 more
    • (no location specified)
    Aug 1, 2022

    Prostate Cancer, BRCA1 Mutation, BRCA2 Mutation Trial (Olaparib, LHRH agonist)

    Not yet recruiting
    • Prostate Cancer
    • +4 more
    • (no location specified)
    Aug 10, 2022

    Germline Variant Carriers With BRCA1 or BRCA2

    Recruiting
    • BRCA1 and/or BRCA2 Variant Carriers
    • +3 more
      • Okayama, Japan
        Okayama University
      Dec 25, 2022

      Breast Cancer After Ovarian Cancer During and/or After Therapy:

      Recruiting
      • BRCA-Associated Breast Carcinoma
      • Next-generation sequencing (NGS) assay TruSight Oncology 500 (TSO 500).
      • Rome, RM, Italy
        Fondazione Policlinico Universitario Agostino Gemelli IRCCS
      Mar 9, 2023

      Hereditary Breast and Ovarian Cancer Trial in Cologne, Kiel, Munich (Structured exercise training plus mediterranean diet)

      Active, not recruiting
      • Hereditary Breast and Ovarian Cancer
      • Structured exercise training plus mediterranean diet
      • Cologne, Germany
      • +2 more
      Oct 25, 2022

      Metastatic Castration-resistant Prostate Cancer Trial in Guangzhou (Pamiparib)

      Recruiting
      • Metastatic Castration-resistant Prostate Cancer
      • Guangzhou, Guangdong, China
        Sun Yat-sen University Cancer Center
      Apr 7, 2022

      Recurrent Metastatic Melanoma, Cutaneous Melanoma, Mucosal Melanoma Trial in Boston (Olaparib)

      Not yet recruiting
      • Recurrent Metastatic Melanoma
      • +3 more
      • Boston, Massachusetts
      • +1 more
      Jul 29, 2022

      Women With Mutations in the Breast Cancer Susceptibility Genes BRCA1,2 Trial in Stockholm (Mifepristone)

      Completed
      • Women With Mutations in the Breast Cancer Susceptibility Genes BRCA1,2
      • Stockholm, Sweden
        Department of Woman and Child Health Karolinska University Hospi
      Jan 15, 2022

      Advanced Malignant Tumor, ATM Gene Mutation, BRCA1 Gene Mutation Trial in Houston (Laboratory Biomarker Analysis,

      Active, not recruiting
      • Advanced Malignant Neoplasm
      • +7 more
      • Laboratory Biomarker Analysis
      • +2 more
      • Houston, Texas
        M D Anderson Cancer Center
      Feb 21, 2022

      Advanced Breast Cancer, HER2/Neu Negative, Triple-Negative Breast Cancer Trial in Stanford (Talazoparib Tosylate)

      Active, not recruiting
      • Advanced Breast Cancer
      • +2 more
      • Talazoparib Tosylate
      • Stanford, California
        Stanford University Hospitals and Clinics
      Nov 16, 2022

      Early HER2-negative High-risk Breast Cancer and BRCA1/2

      Not yet recruiting
      • Breast Cancer
        • Arkhangelsk, Russian Federation
        • +19 more
        Jul 3, 2023

        InheriteD brEast caNcer iTalian regIsTrY A

        Recruiting
        • Breast Cancer
          • Aviano, Pordenone, Italy
          • +11 more
          Apr 26, 2023

          Genes Contributing to Hereditary Ovarian Cancer in Women and

          Completed
          • Ovarian Cancer
            • Seattle, Washington
              University of Washington
            Feb 2, 2022

            BRCA1/2 Mutation Trial in Philadelphia (INO-5401, INO-9012, Cellectra 2000)

            Recruiting
            • BRCA1/2 Mutation
            • Philadelphia, Pennsylvania
              University of Pennsylvania
            Dec 7, 2021

            Impact of Positive BRCA1/2 Mutation Status on Lives of Young

            Completed
            • BRCA1 Gene
            • BRCA2 Gene
              • Bethesda, Maryland
                National Cancer Institute (NCI), 9000 Rockville Pike
              Nov 26, 2021